CYBERDYNE Inc.

In News

CYBERDYNE Inc. 2026 Q4 - Results - Earnings Call Presentation (OTCMKTS:CYBQY) 2026-05-14 - Seeking Alpha

Seeking Alpha - May 14, 2026

CYBERDYNE Inc.'s (TSE:7779) Earnings Haven't Escaped The Attention Of Investors - simplywall.st

simplywall.st - Jan 13, 2026

CYBERDYNE Stock Soars 11.15% to Intraday High Amid Market Decline - Markets Mojo

Markets Mojo - May 18, 2026

Exoskeleton Market Size, Top Share, Growth Forecast by 2033 - Straits Research

Straits Research - Jul 01, 2025

Innovative Cybernics Technologies - JAPAN HOUSE Los Angeles

JAPAN HOUSE Los Angeles - Oct 30, 2020

Cyberdyne's Medical Exoskeleton Strides to FDA Approval - IEEE Spectrum

IEEE Spectrum - Jan 23, 2018

Japan firm's wearable robot suits to help injured Ukraine soldiers - Japan Wire by Kyodo News

Japan Wire by Kyodo News - Nov 30, 2024

7779 Stock Price and Chart — TSE:7779 - TradingView

TradingView - Jul 29, 2017

Revolutionary Robotic Treatment For Patients With Spinal Cord Injuries Now Available In United States - PR Newswire

PR Newswire - Mar 02, 2018

CYBERDYNE’s Medical HAL Obtains FDA Marketing Clearance as Class II Medical Device - Exoskeleton Report

Exoskeleton Report - Dec 22, 2017

Cyberdyne’s rehabilitation exosuit arrives in the US - Medical Device Network

Medical Device Network - Mar 02, 2018

Hybrid Assistive Limb (HAL) improves gait ability in patients with ALS - EurekAlert!

EurekAlert! - Mar 17, 2022

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment